Prostanozol
From Self-sufficiency
180px | |
Clinical data | |
---|---|
Routes of administration | Oral |
Identifiers | |
ATC code | none |
Chemical data | |
Formula | C25H38N2O2 |
Molar mass | 398.580 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Prostanozol is an anabolic steroid designer drug which is a prodrug of the 17-demethylated analogue of stanozolol (Winstrol). It was found in 2005 as an ingredient of products sold as "dietary supplements" for bodybuilding.[1]
References
- ↑ Eenoo PV, Delbeke FT. Metabolism and excretion of anabolic steroids in doping control—New steroids and new insights. Journal of Steroid Biochemistry and Molecular Biology. 2006;101(4-5):161-178. doi:10.1016/j.jsbmb.2006.06.024
45px | This drug article relating to the gastrointestinal system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Anabolic steroids
- Tetrahydropyrans
- Gastrointestinal system drug stubs